Keywords: طراحی دارو ; 9c; 9-cis retinoic acid; AF1 (or 2); activation function 1(or 2); AR; androgen receptor; CAR; constitutive androstane receptor; ChIP; chromatin immunoprecipitation; DBD; DNA binding domain; ER; estrogen receptor; ERE; estrogen response elements; GR; gluco
مقالات ISI طراحی دارو (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: طراحی دارو ; Oxoeicosanoid receptor 1; GPCR; Drug design; Inflammation; Molecular dynamics;
Keywords: طراحی دارو ; Hematopoietic prostaglandin D synthase; Crystal water molecule; Interaction energy; Fragment molecular orbital method; Crystal structure analysis; Drug design;
Keywords: طراحی دارو ; Malaria; Glucose-6-phosphate dehydrogenase; Plasmodium falciparum; Homology modeling; Selective inhibitors; Drug design;
Keywords: طراحی دارو ; Molecular docking; Drug design; Chalcones; Organic synthesis; Anti-bacterial activity;
Keywords: طراحی دارو ; Biological activity; Drug design; Pharmacophore; Structural proteome; Virtual screening;
Keywords: طراحی دارو ; Coumarin; Drug design; Enzyme inhibition; Hybrid heterocycles; Neurodegeneration; Molecular diversity;
Keywords: طراحی دارو ; Ligustrazine derivatives; Pharmacological activities; Drug design; Antioxidation; Anticardiovascular disease; Anticancer; Neuroprotective; Antibacterial; Anti-inflammatory;
Keywords: طراحی دارو ; TLR9; Inflammation; Antagonist; Drug design; Pharmacokinetics;
Keywords: طراحی دارو ; Metronidazole; Imidazole derivatives; Structure-toxicity relationship; Liposomes; Monolayers; Molecular dynamics simulations; Drug design; DPPC; dipalmitoylphosphatidylcholine; Log Do/w; distribution coefficient using an octanol/water system; Log DDS; d
Keywords: طراحی دارو ; Indole; Anti-cancer; Cytotoxic activity; Drug design;
Keywords: طراحی دارو ; UKJDZGMKCIFXFI-FVALVINRSA-N; BGEKALKTMWNTQD-RFIQQHCTSA-N; CQIMLMYPHBOQSL-RFIQQHCTSA-N; IRAOESAINDQEIG-UUOLGLRASA-N; VAKQHCQRJMYBJV-YAZVLAJYSA-N; FNRQKKGAOVAEOI-ABUSLMHJSA-N; DAVUQBKACMLZJU-IGXOHMADSA-N; GGLYYGLRTMUIDR-YMIIJLGTSA-N; OPIFYJPCQJSGJM-KFQSXEOQ
Keywords: طراحی دارو ; blood-brain barrier; permeability; in vitro models; CNS; drug-like properties; drug design;
Keywords: طراحی دارو ; Flavivirus; Capsid protein; Drug design; Antiviral; Review;
Keywords: طراحی دارو ; Drug design; Molecular selectivity; Molecular dynamics; MM-GBSA; Coumarin derivatives; MAO;
Keywords: طراحی دارو ; Drug design; Isoform selectivity;
Intelligent substance delivery into cells using cell-penetrating peptides
Keywords: طراحی دارو ; CPP; cell-penetrating peptide; PTD; protein transduction domain; siRNA; small interfering ribonucleic acid; HIV-1; human immunodeficiency virus 1; Arg; arginine; Lys; lysine; Rn; polyarginine composed of n arginines, where n is natural number; a.a.; amino
Keywords: طراحی دارو ; Naphthalene diimides; Drug design; DNA; G-quadruplex; Telomeric DNA; Topoisomerase; Antiproliferative; BASASA; Boltzmann Accessible Solvent Accessible Surface Area; BCL-2; B-cell lymphoma 2; dsDNA; double-stranded DNA; hTel; human telomeric; HSP90; heat s
Keywords: طراحی دارو ; Covalent drugs; Drug design; Binding kinetics; Docking;
Keywords: طراحی دارو ; Docking; Tensor train; Protein-ligand complex; Protein moveable atoms; Flexible ligand; Drug design;
Keywords: طراحی دارو ; HDAC; PTEN; HNSCC; PI3K/Akt/mTOR; Drug design; Anti-cancer;
Keywords: طراحی دارو ; Cyclin dependent kinases; Cyclins; CDK inhibitors; Drug design; Cancer;
Keywords: طراحی دارو ; Multi-targeted agents; Anticancer therapy; Multi-pharmacophore modes; Pharmacophore combination; Drug design;
Keywords: طراحی دارو ; 5-FC; 5-fluorocytosine; 5-FU; 5-fluorouracil; 6-MeP; 6-methylpruine; 6-MeP-dR; 6-methylpurine-2-deoxyriboside; 9-AC; 9-aminocamptothecin; 9-ACG; 9-aminocamptothecin glucuronide; ACV; acyclovir; ADEPT; antibody-directed enzyme prodrug therapy; API; active
Keywords: طراحی دارو ; Ligand conformations; Protein-ligand docking; Drug design; Octree-based clustering; N-dimensional clustering; In situ analytics;
Keywords: طراحی دارو ; Tumor acidosis; Tumor metabolism; Cancer therapy; Ion trapping; Drug design;
Keywords: طراحی دارو ; Proteasome inhibitors; Phthalazinone; Triphenylphosphine; Drug design; Structure-activity relationship;
Keywords: طراحی دارو ; Drug design; Microtubules; Microtubule-binding agents; Thiocolchicine; Tubulin structure; MT; Microtubules; MTBCs; MT-targeting bivalent compounds; MDA; microtubule depolymerizing agent; MSA; microtubule stabilizing agent; TH; thiocolchicine; THdim-S; sho
Keywords: طراحی دارو ; Cyclic voltammetry; Cytotoxicity; Drug design; Mannich bases; Structure–activity relationship
Keywords: طراحی دارو ; transdermal; drug transport; metabolism; protein binding; drug design; stability; AUC; area under the curve; CA; cortienic acid; CBG; corticosteroid-binding globulin (a.k.a. transcortin); GR; glucocorticoid receptor; HC; hydrocortisone; LE; loteprednol et
Keywords: طراحی دارو ; Drug design; Peptido vinyl sulfonyl fluoride; Proteasome; Irreversible inhibition; Dual warhead;
Keywords: طراحی دارو ; HIV/AIDS; pharmacokinetics; computational biology; Monte Carlo; drug design; mathematical model; mucosal delivery; dynamic simulation; in silico modeling; biophysical models;
Keywords: طراحی دارو ; Tubulin inhibitors; Drug design; Qsar; Molecular docking; Associative Neural Networks (ASNN);
Keywords: طراحی دارو ; MDCK cells; permeability; drug design; structure-activity relationship; solubility;
Keywords: طراحی دارو ; Drug design; Protein-protein interaction; Structure; Small molecule; Antibody; Peptide; Peptidomimetic; Design de médicaments; Interaction protéine-protéine; Structure; Petite molécule; Anticorps; Peptide; Peptidomimétiques;
Keywords: طراحی دارو ; Drug design; Synthesis; Rilmenidine; Doxorubicin synergism; α2-Adrenoceptors; Cytotoxic activity; Apoptosis
Keywords: طراحی دارو ; Fragment molecular orbital method; Influenza virus neuraminidase; Hydration of ligands; Solvation energy; Oseltamivir; Zanamivir; N-acetylneuraminic acid; Drug design;
Keywords: طراحی دارو ; Human disease network; Human disease-related genes network; Gene-disease associations; Drug design
Keywords: طراحی دارو ; Intrinsic thermodynamics of protein-ligand binding; Carbonic anhydrase; Benzenesulfonamide inhibitors; Fluorescent thermal shift assay; Isothermal titration calorimetry; Drug design;
Keywords: طراحی دارو ; blood-brain barrier; CNS; complexation; cyclodextrins; drug design; log P; molecular modeling; physicochemical properties; prodrugs;
Keywords: طراحی دارو ; 2,4-Diaminopyrimidine; Plasmodium falciparum; Antimalarials; Drug design; Tyrosine kinase inhibitors; K1 strain; JAK2 kinase; DCCVVSLWVBTRLY-UHFFFAOYSA-N;
Keywords: طراحی دارو ; Protein structure; Protein misfolding diseases; Drug design; Hemoglobin; Prions; Alzheimer's disease; Retromer;
Keywords: طراحی دارو ; Structure-activity relationship; Drug design; Curcumin derivatives/analogues; Antioxidant activity; Physico-chemical analyses;
Keywords: طراحی دارو ; DHLA; dihydrolipoic acid; DMEM; Dulbecco's Modified Eagle's Medium; EDTA; ethylenediaminetetraacetic acid; FBS; foetal bovine serum; GPx; glutathione peroxidase; GSH; glutathione; GSSG; glutathione disulphide; HPLC; high performance liquid chromatogra
Keywords: طراحی دارو ; Structure–activity relationship study; Drug design; Paraben; Gallate; Mitochondrial complex II; Black leaf spot disease
Keywords: طراحی دارو ; Atherosclerosis; Cigarette smoke; Aryl hydrocarbon receptor antagonists; Molecular modeling; Drug design
Keywords: طراحی دارو ; Acetylcholinesterase inhibitors; Alzheimer's; Pharmacophore; Molecular docking; Drug design
Keywords: طراحی دارو ; drug-like properties; operating models in discovery; physicochemical properties; Drug Design; ADMET properties; insilico modeling; in-vitro models;target therapeutic profile (TPP); developability risk assessment; MAD; rule of five;
Keywords: طراحی دارو ; Epigenetics; Post-translational modifications; Histone; Computer-aided molecular design; Drug design; Drug discovery
Keywords: طراحی دارو ; biobetter; drug design; molecular modeling; monoclonal antibody; mutation; protein aggregation; rituximab; SAP; stabilization;